"Ltd. "SPC" Katyusha" |
|||||||||||||||||||||||||||||||
Project Summary
History. .
In the late seventies of 20 th - century, a team of LTI Lensoviet under the leadership of Anatoly Loskutov, jointly developed with a group of doctors and the Ministry of Health has received a registration certificate USSR № 79/7666 -66 "for the inclusion in nomenclature allowed for use in medical practice and batch production of medical equipment "under the title" Carbon Adsorbent medical SKT-6A (high purity). As a based industrial sorbent SKT 6A was taken, after demineralization operations and disposal of dust it can be used as a sorbent for the treatment of blood outside the body (extracorporal haemokorrektion) and enterosorbent.
Sorbent was presented in 1980 at the International Health Exhibition "- 80" in Moscow, and was marked by an honorary diploma of the exhibition. Later on in 1982 specialists of LTI and LMPI ( Tsybulkin E.K, Shiskina L.I. and others) was jointly developed and patented successful method of treatment the giperbilirubinemiya of newborn by using haemosorption , this method has been successfully used in the treatment of more than 3000 newborn in Leningrad. Sorbent was successfully applied in many clinics of the USSR. Packed in sterile vials, haemosorbent under various names is now produced by small Russian companies. The dust generation and not fully sufficient for modern requirements restricts its production and distribution, however, as other domestic sorbents. Company Ltd. "SPC" Katyusha " founded on November 18, 2005 as a result of victory in the competition "Start", organised by the Faundation for Assistance to Small Innovative Enterprises in the scientific and technical sphere. Application № 05-2 - N3-0318: "The completion of R & D for the creation of industrial production of the high mezoporous sorbents and the equipment for the production of the new type of massexchangers for their application in the integrated treatment of such diseases as burns, AIDS, drugs, alcohol deliriy, etc. " In Ltd. "SPC" Katyusha " employs three chemical technologist attending the design, certification and manufacture of medical sorbents (Anatoly Loskutov, Averkov Alexander, Fedotov Valery), and two doctors (Alexei Sokolov and Shishkina Lyudmila ), specialists for application of sorbents in clinics. Management
The leaders and key professionals, age, education, academic degree, the experience of projects involving investment and management expertise.
Averkov Alexander Valerevich. commercial director , 41 years old. Works in the field of medical sorbents technology since 1983. Has extensive experience to create business "from scratch", and to develope a strategy of the customer service. Co-author of 6 inventions.
Anatoly Loskutov Iosifovich. CEO, 70 years. Ph.D. in Chemistry Works in the field of sorbents technology since 1961 Specialist in chemically modified carbon sorbents and superpure substances. Developed wastefree or low-waste technology of components leaching from solid grain materials, author of 200 scientific papers and 30 inventions.
Sokolov.Alexei Albertovich. Research Consultant, 39 years. PhD, MD. He has varied medical specialization (intensive therapy, nephrology, immunology, clinical laboratory diagnostics, transfuziologiya). He uses in clinics all methods of extracorporal haemocorrection, has big experience in scientific research and practical experience in the clinical application of adsorbents for more than 20 years. The author of 110 scientific publications, patents 3. Secretary of the Russian Society of Professional haemoferez and the blood purification.
Fedotov Valery Alexeevich. Research Consultant (Chemistry), 46 years. Ph.D. in Chemistry, has very reach experience in.preparation and study the properties of fluorinated carbon sorbents, inventor of supermezoporous carbon sorbents.
Shishkina Lyudmila Ivanovna. Research Consultant (Medicine), 60. Head of the express-laboratory of the Military Medical Academy, PhD, MD. She has more than 60 published works end 8 inventions. She is the co-author of the method of cleaning the blood from bilirubin. The method has successfully been applied in Leningrad for the treatment of newborn babies (more than 3000 operations).
Over the years, our group has advanced in the field of chemical modification of carbon sorbents. Tackled the task of creating the micro- and mesoporous sorbents with polymer film coating of their granulas without causing significant loss of surface and sorption capacity. All processes developed on the scale industrial equipment. Our columns have the special device to prevent dust generation during their transportation and keeping. The dynamics of development in recent years
Implemented following:
Won the contest of projects under the program "Start - 05", and concluded a contract with the State Foundation promote the development of small enterprises in scientific and technical sphere. Contract № 3663 R/ 6169 of 26.12.2005. Implemented: -- it was fulfilled the design of the plant installation for production of medical carbon adsorbents of high purity; -- it was done the harmonization of project with firefighters, environmentalists and workers of the healthprotection and safety; -- Construction of new columns; -- 6 applications for invention; -- acquired and delivered the equipment and materials necessary for the operation of the plant for producing medical sorbents at the territory of GIPH Pilot Plant; -- supporting work (replanning of the working rooms, design and production of the reference frames for the thermotreatment furnaces, the stands for cooling quartz glass retorts with sorbent, stands for downloading the retorts, a pillar for the washing column assembly line and vacuum collecting apparatus); -- Installation of equipment; -- a test launch of installation art with 500 kg SKT-6A HF required to perform research and development on the "START-2006"; -- developed the industrial technology of sorbents dedusting; -- developed the industrial technology of chemically modifide carbon sorbents; -- developed the industrial technology of the covering the sorbents granules by PTFE film; -- industrial technology of the superpure oxidized sorbent production; -- it was prepared 3 new types of sorbent in the volume of industrial production; -- manufactured experimental samples of the vials-columns with sorbent; -- participated in the eighth Fair venture projects 8-10 October 2007 in St. Petersburg. 2006, financed from the Fund for Assistance to Small Innovative Enterprises in the scientific and technical sphere. The investments that have already been undertaken at the company - 3000 000 roubles, including: the founders own funds invested in a previously established with our own money installation of additional equipment and consumables total reserve in the amount of: 2 250 000 roubles; disbursed funds for program "Start-05" at the amount of 750 000. roubles. Description of business ideas, product
Bring on the Russian market world-class products
Perform international patenting of the PCT. The total number of patents needed 6 pc. protected in the territory of the European Union, China, India, Africa, the United States and Canada. Produce experimental samples and to sell licenses to foreign companies. In Russia, to organize a modern high-tech production of sterile disposable columns with sorbent (Saint Petersburg) in the amount necessary for the Russian market, or to organize the sale of products manufactured under license western partner. . To effectively move on the territory of Russia to issue two successive line of products: -- in the first stage of column-bottles of glass hull; -- in the second phase polymer columns. The task of the first phase: to occupy a niche in the market of inexpensive haemosorbents. Through good transportabelnosti arrange their sale throughout Russia. The advantage would be: * -- availability of built-filter, ensuring sterility in the preparation for the operation; -- availability of the device, preventing generation of dispersed particles during transportation and storage; -- good portability transportation; -- mezoporistaya sorbent structure; -- gemosovmestimost good at the expense of a unique polymer coating. Tactics combine direct sales and promotion through the dealer network The task of the second phase: Exclusion from the market sorbents in columns production in Ukraine. To use the solution to the already established distribution network. The advantage would be: -- there are two filters built to enable connection of the columns in any direction and position in space; -- availability of the device, preventing generation of dispersed particles during transportation and storage; -- good portability transportation; -- high readiness for the operation - shorten the time required for cleaning dust - our original sorbent SKT 6 and contains much dust, but is allowed in columns STO -- up to 5%, with a column gemosorbentom SKT-6a high purity, which granules fluoric plastic covered with a thin film of mesoporous changed or will contain no more than 0.5% of dust; -- Reduction of time preparing for an operation by 2-3 times; -- especially sorbent - not inferior to sorption capacity and the size and number of mesopore but superior to the JMC gemosovmestimosti through a unique polymer coating and the stock price strength. Also planned, in accordance with demand, introduce additional line of sorbents with highly selective and imunosorbenty. To take up to 65% of the Russian market hemosor non-selective. Exit to the markets of the Soviet Union, India, China and Latin America. At this stage, or during its preparation, it is desirable to sell shares of venture investor strategic partner, as the most interesting of which can make a major Western pharmaceutical company such as: Fresenius Medical Care AG, or Gambro. Description of products, the degree of its novelty.
We have developed a complete product - sterile, single use column with the sorbent. The novelty consists in the construction of columns, and the properties of the sorbent. The main advantages of this column: -- Column done precluded the formation of technology in the manufacture; -- Column, fitted with a device preventing formation during storage and transportation; -- Column equipped with a built-filter to prevent dispersion of particles in the blood; -- Column staffing provides connectivity to the majority of hemodialysis machines and hemosorption; -- Column filled sorbent responsible modern world requirements for products of this class; Applied for an invention in FIPS requires international patenting. Sorbent is made on the basis of easily produced in quantities of up to 200 tons per year of industrial sorbent SKT-6a.; Sorbent passes two stages of purification and chemical modifications of two stages. The result obespylenny, sorbent with a low ash content, and mesoporous with a polymer coating (There were three applications for invention in FIPS, demineralization method, the method and the meta obespylivaniya causing polymer coating, requires international patenting); Thanks mesoporous structure of the sorbent it could produce and Ruler imunosorbentov, whose market in Russia is estimated at 150 million rubles. The technology of obtaining effective hemosorbent. As a raw material used by the Russian industry produced carbon adsorbent marks SKT-6a. He performed for more than 30 years. The same patented equipment filling line. There are currently 6 filed applications and one has already received a positive decision, and the rest are under consideration. Patents on all inventions and utility models LLC "CPP" Katyusha" or patented to SIA "CPP"Katyusha". Potential Market
Rossi need of medical facilities is estimated at about 48 000 columns a year, which is 80-120 million rubles.
The volume of the world market directly proportional to the population and taking into account the higher world price is not less than $ 150-220 million The demand has been steadily increasing, at least 10% a year, because of the deteriorating ecological environment, the rise of drug abuse, the number of AIDS
We look forward to a significant increase in demand in the market withdrawal developed by us columns by simplifying procedures hemosorption, reduce injury uniform elements of blood, the price reduction as compared with foreign counterparts and the resulting expansion of the scope of hemosorption in medicine. In the absence of inexpensive analogs on the market by 2011, we plan to capture up to 65% of the Russian market. Promising markets will CIS (the market at least $ 1 million), , South America, China and India (the market is not less than $15 million). Exit to the markets of developed countries is planned through co-production with major pharmaceutical corporations, from the sale of patents and licenses (or) on the production. Exiting the investment
The most favorable exit scheme to the investor selling nonblocking packet as a strategic investor which may be offered a major American or European pharmaceutical company. The most auspicious time to 3-5 years of funding (for the period increase in the Russian market). During this period will require increased production and the production and certification of products in accordance with ISO or (and) the willingness of patents (patents for invention (s) or utility model with the results of the respective expertise in key countries). In this role could make Fresenius Medical Care AG (Germany), or 'GAMBRO' (Sweden), producing products for hemodialysis for the European market. About 30% share of the investor's management company plans to buy back at the expense of retained earnings at the time of the sale of shares of Investor. |
|||||||||||||||||||||||||||||||
Contact.
Get a detailed business plan |
|||||||||||||||||||||||||||||||
Society Limited Liability
"Scientific and Production Company" Katyusha "
|
|||||||||||||||||||||||||||||||